Dendreon and Genentech to Collaborate on Trp-p8 Gene Platform
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 28 (Table of Contents)
Published: 2 Sep-2002
DOI: 10.3833/pdr.v2002.i28.1002 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Dendreon entered into a collaborative agreement with Genentech for the research, development and commercialization of monoclonal antibodies, small molecules and other products derived from Dendreon’s Trp-p8 gene platform...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018